These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 3940648)
1. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Johnson VG; Schlom J; Paterson AJ; Bennett J; Magnani JL; Colcher D Cancer Res; 1986 Feb; 46(2):850-7. PubMed ID: 3940648 [TBL] [Abstract][Full Text] [Related]
2. Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3. Sheer DG; Schlom J; Cooper HL Cancer Res; 1988 Dec; 48(23):6811-8. PubMed ID: 3180090 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the shed form of the human tumor-associated glycoprotein (TAG-72) from serous effusions of patients with different types of carcinomas. Katari RS; Fernsten PD; Schlom J Cancer Res; 1990 Aug; 50(16):4885-90. PubMed ID: 2379152 [TBL] [Abstract][Full Text] [Related]
4. Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies. Kuroki M; Fernsten PD; Wunderlich D; Colcher D; Simpson JF; Poole DJ; Schlom J Cancer Res; 1990 Aug; 50(16):4872-9. PubMed ID: 1696162 [TBL] [Abstract][Full Text] [Related]
5. Purification and composition of a novel gastrointestinal tumor-associated glycoprotein expressing sialylated lacto-N-fucopentaose II (CA 19-9). Klug TL; LeDonne NC; Greber TF; Zurawski VR Cancer Res; 1988 Mar; 48(6):1505-11. PubMed ID: 2449952 [TBL] [Abstract][Full Text] [Related]
6. Biochemical and immunological properties of the human carcinoma-associated CAR-3 epitope defined by the monoclonal antibody AR-3. Prat M; Medico E; Rossino P; Garrino C; Comoglio PM Cancer Res; 1989 Mar; 49(6):1415-21. PubMed ID: 2466553 [TBL] [Abstract][Full Text] [Related]
7. Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein. Horan Hand P; Colcher D; Salomon D; Ridge J; Noguchi P; Schlom J Cancer Res; 1985 Feb; 45(2):833-40. PubMed ID: 3881173 [TBL] [Abstract][Full Text] [Related]
8. Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene. Dahiya R; Kwak KS; Byrd JC; Ho S; Yoon WH; Kim YS Cancer Res; 1993 Mar; 53(6):1437-43. PubMed ID: 8443822 [TBL] [Abstract][Full Text] [Related]
10. Colonic tumor membrane-associated glycoprotein: isolation of antigenically-active peptides after chemical cleavage. Leung JP; Eshdat Y; Marchesi VT J Immunol; 1977 Aug; 119(2):664-70. PubMed ID: 69665 [TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of the human adenocarcinoma-associated glycoprotein gp40. Sportsman JR; Taber LD; Slisz MC; Apelgren LD; Bumol TF Biotechnol Appl Biochem; 1988 Dec; 10(6):536-44. PubMed ID: 3069116 [TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of a high molecular weight glycoprotein detectable in human milk and breast carcinomas. Sekine H; Ohno T; Kufe DW J Immunol; 1985 Nov; 135(5):3610-5. PubMed ID: 4045199 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody against human colonic sulfomucin: immunochemical detection of its binding sites in colonic mucosa, colorectal primary carcinoma, and metastases. Yamori T; Ota DM; Cleary KR; Hoff S; Hager LG; Irimura T Cancer Res; 1989 Feb; 49(4):887-94. PubMed ID: 2912559 [TBL] [Abstract][Full Text] [Related]
14. Identification of a Mr 40,000 polypeptide from colorectal cancer which expresses organ-specific cancer neoantigen activity as determined by leukocyte adherence inhibition. Artigas C; Thomson DM; Durko M; Sutherland M; Scanzano R; Shenouda G; Dubois AE Cancer Res; 1986 Apr; 46(4 Pt 1):1874-81. PubMed ID: 2418955 [TBL] [Abstract][Full Text] [Related]
15. Multiple forms of intracellular and secreted mucins in a pancreatic cancer cell line. Ho JJ; Bi N; Siddiki B; Chung YS; Yuan M; Kim YS Cancer Res; 1993 Feb; 53(4):884-90. PubMed ID: 7679052 [TBL] [Abstract][Full Text] [Related]
16. [Preparation and identification of monoclonal antibodies against different epitopes on TAG-72 antigen]. Xu M Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):431-4. PubMed ID: 7515344 [TBL] [Abstract][Full Text] [Related]
17. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity. Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726 [TBL] [Abstract][Full Text] [Related]
18. Tumor-associated glycoprotein expression in salivary gland mucoepidermoid carcinomas: an immunohistochemical study using the monoclonal antibody B72.3. Roa RA; Hruban RH; McKenzie P; Richtsmeier W Laryngoscope; 1994 Mar; 104(3 Pt 1):304-8. PubMed ID: 8127187 [TBL] [Abstract][Full Text] [Related]
19. Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant. Osinaga E; Pancino G; Porchet N; Berois N; De Cremoux P; Mistro D; Aubert JP; Calvo F; Roseto A Breast Cancer Res Treat; 1994; 32(2):139-52. PubMed ID: 7532464 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the antigen recognized by monoclonal antibody 1D3. Gangopadhyay A; Chatterjee SK; Bhattacharya M; Barlow JJ Cancer Biochem Biophys; 1988 Nov; 10(2):107-15. PubMed ID: 3252956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]